US 11,696,911 B2
Antiviral compounds and method for treating RNA viral infection, particularly COVID-19
Tai-Sen Soong, Chino, CA (US)
Assigned to SENHWA BIOSCIENCES, INC., New Taipei (TW)
Filed by SENHWA BIOSCIENCES, INC., New Taipei (TW)
Filed on Mar. 18, 2021, as Appl. No. 17/205,823.
Claims priority of provisional application 63/001,723, filed on Mar. 30, 2020.
Claims priority of provisional application 63/053,908, filed on Jul. 20, 2020.
Prior Publication US 2021/0308110 A1, Oct. 7, 2021
Int. Cl. A61K 31/4745 (2006.01); A61K 31/519 (2006.01); A61K 31/4375 (2006.01); A61P 31/14 (2006.01); A61K 31/437 (2006.01)
CPC A61K 31/4375 (2013.01) [A61K 31/437 (2013.01); A61K 31/519 (2013.01); A61P 31/14 (2018.01)] 6 Claims
 
1. A method for treating an RNA viral infection in a human comprising administering a therapeutically effective amount of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.